Lynn Sullivan

Launching a product in an established category is one challenge. Building belief in an emerging therapeutic area is another. When GLP-1s were still early in obesity and diabetes, success depended not only on strategy, data and messaging, but on creating the internal culture, field confidence and market education needed to turn uncertainty into momentum.

Drawing on experience leading diabetes and obesity commercial teams across the US and global markets, this session will explore how to build the people, tools and operating rhythm behind a high-growth launch, from motivating field teams and aligning affiliates to creating consistent global execution across diverse local markets.

• Building internal belief and field confidence around emerging therapeutic areas

• Aligning global strategy with local market fit across multiple countries

• Using launch platforms, training and KPIs to create execution visibility

• Creating a pioneering culture that turns launch teams into business builders